Literature DB >> 7200859

[Chemotherapy in advanced sarcomas (author's transl)].

W Bierbaum, K Bremer, N Firusian, M Higi, N Niederle, M E Scheulen, C G Schmidt, S Seeber.   

Abstract

43 patients with metastasizing sarcomas were treated with a combination of either vincristin, adriamycin and cis-platinum (n = 21) or ifosfamide and cis-platinum at three weeks' intervals in each case. Ten patients responded to the first combination and nine to the second combination with objective tumor regression. Particularly the latter result is remarkable since 16 of the 22 patients had already been pretreated with combinations containing adriamycin. Obviously the combination of ifosfamide and cis-platinum is a promising alternative in metastasizing sarcomas of the bones and soft tissue, especially if the CYVADIC combination--which is often regarded as standard treatment--remained unsuccessful. This has no bearing on additional surgical measures or on radiotherapy which may be necessary in some patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7200859     DOI: 10.1055/s-2008-1070478

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  8 in total

1.  [Chemotherapy of soft tissue sarcomas].

Authors:  D K Hossfeld; S Seeber; E Siemers; C G Schmidt
Journal:  Langenbecks Arch Chir       Date:  1981

2.  Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma.

Authors:  E Wiltshaw; G Westbury; C Harmer; A McKinna; C Fisher
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility.

Authors:  T Cerny; A Graf; P Rohner; T Zeugin; K W Brunner; A Küpfer
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Alternatives to CYVADIC combination therapy of soft tissue sarcomas.

Authors:  J H Hartlapp; H J Münch; H J Illiger; H Wolter; J C Jensen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people.

Authors:  I Magrath; J Sandlund; A Raynor; S Rosenberg; V Arasi; J Miser
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot study.

Authors:  T H Klippstein; P S Mitrou; K J Kochendörfer; L Bergmann
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Alternatives to CYVADIC-combination therapy of soft tissue sarcomas.

Authors:  J H Hartlapp; H J Münch; H J Illiger; H Wolter; J C Jensen
Journal:  Klin Wochenschr       Date:  1985-11-15

Review 8.  Ifosfamide clinical pharmacokinetics.

Authors:  T Wagner
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.